A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model

被引：0
|
作者：
Shi, H. [1 ]
Johnson, B. [1 ]
Yu, T. -K. [1 ]
Zhuang, L. [1 ]
Selvamani, S. P. [1 ]
Lee, K. [2 ]
Klebe, S. [3 ]
Chen, K. [4 ]
Clark, G. [4 ]
Kao, S. [1 ]
Silveira, P. [4 ]
Cheng, Y. Y. [5 ]
机构：
[1] Asbestos Dis Res Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Flinders Hlth & Med Res Inst, Adelaide, SA, Australia
[4] Anzac Res Inst, Sydney, NSW, Australia
[5] Inst Biomed Mat & Devices IBMD, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
pleural mesothelioma; immune checkpoint inhibitor; mouse model;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.21-02
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [41] Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
    Giosue Scognamiglio
    Annarosaria De Chiara
    Antonina Parafioriti
    Elisabetta Armiraglio
    Flavio Fazioli
    Michele Gallo
    Laura Aversa
    Rosa Camerlingo
    Francesco Cacciatore
    Gianluca Colella
    Roberto Pili
    Filomena de Nigris
    British Journal of Cancer, 2019, 121 : 979 - 982
  • [42] Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma
    Cho, Hiroyuki
    Matsumoto, Seiji
    Fujita, Yoshiko
    Kuroda, Ayumi
    Menju, Toshi
    Sonobe, Makoto
    Kondo, Nobuyuki
    Torii, Ikuko
    Nakano, Takashi
    Lara, Primo N.
    Gandara, David R.
    Date, Hiroshi
    Hasegawa, Seiki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 477 - 490
  • [43] Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model
    Lan, Hongwei
    Zhu, Jingjuan
    Hou, Helei
    Zhang, Chuantao
    Huo, Xingfa
    Zhang, Yuming
    Yang, Fangfang
    Zhou, Na
    Zhang, Xiaochun
    CELL COMMUNICATION AND SIGNALING, 2025, 23 (01)
  • [44] PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
    Neta Rosenzweig
    Raz Dvir-Szternfeld
    Afroditi Tsitsou-Kampeli
    Hadas Keren-Shaul
    Hila Ben-Yehuda
    Pierre Weill-Raynal
    Liora Cahalon
    Alex Kertser
    Kuti Baruch
    Ido Amit
    Assaf Weiner
    Michal Schwartz
    Nature Communications, 10
  • [45] PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
    Rosenzweig, Neta
    Dvir-Szternfeld, Raz
    Tsitsou-Kampeli, Afroditi
    Keren-Shaul, Hadas
    Ben-Yehuda, Hila
    Weill-Raynal, Pierre
    Cahalon, Liora
    Kertser, Alex
    Baruch, Kuti
    Amit, Ido
    Weiner, Assaf
    Schwartz, Michal
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [46] Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer
    Tu, Megan M.
    Ng, Terry L.
    De Jong, Horns C.
    Zuiverloon, Tahlita C. M.
    Fazzari, Francesco G. T.
    Theodorescu, Dan
    BLADDER CANCER, 2019, 5 (02) : 131 - 145
  • [47] PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
    Xu-Monette, Zijun Y.
    Zhang, Mingzhi
    Li, Jianyong
    Young, Ken H.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [48] Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
    Guo, Zhiqiang
    Li, Yan
    Zhang, Dandan
    Ma, Jiaying
    ONCOTARGET, 2017, 8 (52) : 89761 - 89774
  • [49] PD-1 Blockade Enhances the Efficacy of Chemoradiation in a Mouse Model of Esophageal Cancer
    Oh, P.
    Du, K. L.
    Leichman, L.
    Aifantis, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S127 - S128
  • [50] Racotumomab and PD-1 blockade combination exhibits an additive antitumor effect in a non-small cell lung cancer model
    Segatori, Valeria, I
    Gulino, Cynthia A.
    Capobianco, Carla S.
    Rojo, Selene
    Ferreira, Gretel M.
    Cuello, Hector A.
    Gabri, Mariano R.
    Alonso, Daniel A.
    CANCER RESEARCH, 2020, 80 (16)
12345